AIM
WST icon

Acrospire Investment Management’s West Pharmaceutical WST Stock Holding History

Acrospire Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,200
Closed -$113K – 1447
2017
Q2 		$113K Buy
+1,200
New +$110K 0.11% 181
2016
Q4 		– Sell
-500
Closed -$37K – 2451
2016
Q3 		$37K Hold
500
– – 0.02% 1236
2016
Q2 		$38K Buy
500
+300
+150% +$21.8K 0.03% 1256
2016
Q1 		$14K Buy
+200
New +$12K 0.01% 1666

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acrospire Investment Management's WST Position: Q3 2017 in Review

Acrospire Investment Management sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 1,200 shares — an estimated $113K sold.

Acrospire Investment Management first reported a position in WST in Q1 2016 and held it in 4 quarters. The position peaked at $113K in Q2 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Acrospire Investment Management reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,200 West Pharmaceutical shares in Q3 2017, an estimated $113K.
  • Acrospire Investment Management first reported a position in West Pharmaceutical in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's West Pharmaceutical position peaked at $113K in Q2 2017.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.